Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor

Nucleic Acids Research

Volumn 40, Issue 19, 2012, Pages 9513-9521

  Neault, Mathieu ^a   Mallette, Frédérick A ^a   Vogel, Gillian ^a   Michaud Levesque, Jonathan ^a   Richard, Stéphane ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 6; PROTEIN P21; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; CELL AGING; CELL DAMAGE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE SILENCING; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; TRANSCRIPTION REGULATION; TRP53 GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL AGING; CELLS, CULTURED; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; PROTEIN-ARGININE N-METHYLTRANSFERASES; RAS PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84868110617     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks764     Document Type: Article

References (55)

1. Bedford, M.T. and Richard, S. (2005) Arginine methylation an emerging regulator of protein function. Mol. Cell, 18, 263-272. (Pubitemid 41350532)
2. Bedford, M.T. and Clarke, S.G. (2009) Protein arginine methylation in mammals: who, what, and why. Mol. Cell, 33, 1-13.
3. Zurita-Lopez, C.I., Sandberg, T., Kelly, R. and Clarke, S.G. (2012) Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming o-NG-monomethylated arginine residues. J. Biol. Chem., 287, 7859-7870.
4. Frankel, A., Yadav, N., Lee, J., Branscombe, T.L., Clarke, S. and Bedford, M.T. (2002) The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J. Biol. Chem., 277, 3537-3543. (Pubitemid 34953224)
5. Lakowski, T.M. and Frankel, A. (2008) A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism. J. Biol. Chem., 283, 10 015-10025.
6. Obianyo, O. and Thompson, P.R. (2012) Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6). J. Biol. Chem., 17, 6062-6071.
7. Boulanger, M.C., Liang, C., Russell, R.S., Lin, R., Bedford, M.T., Wainberg, M.A. and Richard, S. (2005) Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J. Virol., 79, 124-131. (Pubitemid 39648370)
8. Invernizzi, C.F., Xie, B., Frankel, F.A., Feldhammer, M., Roy, B.B., Richard, S. and Wainberg, M.A. (2007) Arginine methylation of the HIV-1 nucleocapsid protein results in its diminished function. AIDS, 21, 795-805. (Pubitemid 46578071)
9. Invernizzi, C.F., Xie, B., Richard, S. and Wainberg, M.A. (2006) PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA. Retrovirology, 3, 93.
10. El-Andaloussi, N., Valovka, T., Toueille, M., Steinacher, R., Focke, F., Gehrig, P., Covic, M., Hassa, P.O., Schar, P., Hubscher, U. et al. (2006) Arginine methylation regulates DNA polymerase beta. Mol. Cell, 22, 51-62.
11. Miranda, T.B., Webb, K.J., Edberg, D.D., Reeves, R. and Clarke, S. (2005) Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. Biochem. Biophys. Res. Commun., 336, 831-835. (Pubitemid 41338343)
12. Di Lorenzo, A. and Bedford, M.T. (2011) Histone arginine methylation. FEBS Lett., 585, 2024-2031.
13. Lee, D.Y., Teyssier, C., Strahl, B.D. and Stallcup, M.R. (2004) Role of Protein Methylation in Regulation of Transcription. Endocr. Rev., 26, 147-170.
14. Kouzarides, T. (2007) Chromatin modifications and their function. Cell, 128, 693-705. (Pubitemid 46273577)
15. Guccione, E., Bassi, C., Casadio, F., Martinato, F., Cesaroni, M., Schuchlautz, H., Luscher, B. and Amati, B. (2007) Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature, 449, 933-937. (Pubitemid 47598605)
16. Kirmizis, A., Santos-Rosa, H., Penkett, C.J., Singer, M.A., Vermeulen, M., Mann, M., Bahler, J., Green, R.D. and Kouzarides, T. (2007) Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature, 449, 928-932. (Pubitemid 47598603)
17. Hyllus, D., Stein, C., Schnabel, K., Schiltz, E., Imhof, A., Dou, Y., Hsieh, J. and Bauer, U.M. (2007) PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev., 21, 3369-3380. (Pubitemid 350277762)
18. Iberg, A.N., Espejo, A., Cheng, D., Kim, D., Michaud-Levesque, J., Richard, S. and Bedford, M.T. (2008) Arginine methylation of the histone H3 tail impedes effector binding. J. Biol. Chem., 283, 3006-3010.
19. Waldmann, T., Izzo, A., Kamieniarz, K., Richter, F., Vogler, C., Sarg, B., Lindner, H., Young, N.L., Mittler, G., Garcia, B.A. et al. (2011) Methylation of H2AR29 is a novel repressive PRMT6 target. Epigenetics Chromatin, 4, 11.
20. Michaud-Levesque, J. and Richard, S. (2009) Thrombospondin-1 is a transcriptional repression target of PRMT6. J. Biol. Chem., 284, 21 338-21346.
21. Harrison, M.J., Tang, Y.H. and Dowhan, D.H. (2010) Protein arginine methyltransferase 6 regulates multiple aspects of gene expression. Nucleic Acids Res., 38, 2201-2216.
22. Michaloglou, C., Vredeveld, L.C., Soengas, M.S., Denoyelle, C., Kuilman, T., van der Horst, C.M., Majoor, D.M., Shay, J.W., Mooi, W.J. and Peeper, D.S. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature, 436, 720-724. (Pubitemid 41117276)
23. Larsson, L.G. (2011) Oncogene-and tumor suppressor gene-mediated suppression of cellular senescence. Semin. Cancer Biol., 21, 367-376.
24. Rodier, F. and Campisi, J. (2011) Four faces of cellular senescence. J. Cell Biol., 192, 547-556.
25. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O. et al. (1996) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA, 92, 9363-9367.
26. Ferbeyre, G., de Stanchina, E., Lin, A.W., Querido, E., McCurrach, M.E., Hannon, G.J. and Lowe, S.W. (2002) Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol., 22, 3497-3508. (Pubitemid 34453988)
27. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P.P. et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature, 406, 207-210. (Pubitemid 30469006)
28. Kunz, C., Pebler, S., Otte, J. and von der Ahe, D. (1995) Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res., 23, 3710-3717.
29. Zhao, W., O'Malley, Y., Wei, S. and Robbins, M.E. (2000) Irradiation of rat tubule epithelial cells alters the expression of gene products associated with the synthesis and degradation of extracellular matrix. Int. J. Radiat. Biol., 76, 391-402. (Pubitemid 30137746)
30. Kortlever, R.M., Higgins, P.J. and Bernards, R. (2006) Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol., 8, 877-884.
31. de Stanchina, E., Querido, E., Narita, M., Davuluri, R.V., Pandolfi, P.P., Ferbeyre, G. and Lowe, S.W. (2004) PML is a direct p53 target that modulates p53 effector functions. Mol. Cell, 13, 523-535. (Pubitemid 38299380)
32. McConnell, B.B., Starborg, M., Brookes, S. and Peters, G. (1998) Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol., 8, 351-354. (Pubitemid 28159123)
33. Carrier, F., Smith, M.L., Bae, I., Kilpatrick, K.E., Lansing, T.J., Chen, C.Y., Engelstein, M., Friend, S.H., Henner, W.D., Gilmer, T.M. et al. (1994) Characterization of human Gadd45, a p53-regulated protein. J. Biol. Chem., 269, 32 672-32677.
34. Tront, J.S., Hoffman, B. and Liebermann, D.A. (2006) Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res., 66, 8448-8454. (Pubitemid 44449156)
35. Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C. and Lowe, S.W. (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev., 14, 2015-2027. (Pubitemid 30637352)
36. Jones, B., Su, H., Bhat, A., Lei, H., Bajko, J., Hevi, S., Baltus, G.A., Kadam, S., Zhai, H., Valdez, R. et al. (2008) The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet., 4, e1000190.
37. Yu, Z., Chen, T., Hé bert, J., Li, E. and Richard, S. (2009) A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol. Cell. Biol., 29, 2982-2996.
38. Mallette, F.A., Gaumont-Leclerc, M.F. and Ferbeyre, G. (2007) The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev., 21, 43-48. (Pubitemid 46089705)
39. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M. and Smith, J.R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211, 90-98. (Pubitemid 24167339)
40. Lujambio, A. and Lowe, S.W. (2012) The microcosmos of cancer. Nature, 482, 347-355.
41. Vigneron, A. and Vousden, K.H. (2010) p53, ROS and senescence in the control of aging. Aging, 2, 471-474.
42. Lin, A.W., Barradas, M., Stone, J.C., van Aelst, L., Serrano, M. and Lowe, S.W. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev., 12, 3008-3019. (Pubitemid 28469303)
43. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. and Lowe, S.W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88, 593-602. (Pubitemid 27152402)
44. Rowland, B.D., Bernards, R. and Peeper, D.S. (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol., 7, 1074-1082.
45. Okoshi, R., Ando, K., Suenaga, Y., Sang, M., Kubo, N., Kizaki, H., Nakagawara, A. and Ozaki, T. (2009) Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation. Genes Cells, 14, 1429-1440.
46. Raman, V., Martensen, S.A., Reisman, D., Evron, E., Odenwald, W.F., Jaffee, E., Marks, J. and Sukumar, S. (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature, 405, 974-978. (Pubitemid 30435057)
47. Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A.H., Schlegelberger, B., Stein, H., Dorken, B., Jenuwein, T. and Schmitt, C.A. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature, 436, 660-665. (Pubitemid 41117262)
48. Chen, Z., Trotman, L.C., Shaffer, D., Lin, H.K., Dotan, Z.A., Niki, M., Koutcher, J.A., Scher, H.I., Ludwig, T., Gerald, W. et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature, 436, 725-730. (Pubitemid 41117277)
49. Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J., Barradas, M., Benguria, A., Zaballos, A., Flores, J.M., Barbacid, M. et al. (2005) Tumour biology: senescence in premalignant tumours. Nature, 436, 642. (Pubitemid 41117258)
50. Lin, H.K., Chen, Z., Wang, G., Nardella, C., Lee, S.W., Chan, C.H., Yang, W.L., Wang, J., Egia, A., Nakayama, K.I. et al. (2010) Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature, 464, 374-379.
51. Ventura, A., Kirsch, D.G., McLaughlin, M.E., Tuveson, D.A., Grimm, J., Lintault, L., Newman, J., Reczek, E.E., Weissleder, R. and Jacks, T. (2007) Restoration of p53 function leads to tumour regression in vivo. Nature, 445, 661-665. (Pubitemid 46232887)
52. Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C. and Lowe, S.W. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature, 445, 656-660. (Pubitemid 46232886)
53. Lim, Y., Lee, E., Lee, J., Oh, S. and Kim, S. (2008) Down-regulation of asymmetric arginine methylation during replicative and H2O2-induced premature senescence in WI-38 human diploid fibroblasts. J. Biochem., 144, 523-529.
54. Yoshimatsu, M., Toyokawa, G., Hayami, S., Unoki, M., Tsunoda, T., Field, H.I., Kelly, J.D., Neal, D.E., Maehara, Y., Ponder, B.A. et al. (2011) Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int. J. Cancer, [Journal International du Cancer], 128, 562-573.
55. Rowland, B.D. and Peeper, D.S. (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nature reviews. Cancer, 6, 11-23. (Pubitemid 43053649)